The Rise of Population-scale Genomic Projects for Pharma R&D Investments
With the announced $400 million investment from global investors including the Irish sovereign fund, Genuity Science (formerly WuXi NextCODE) announced that GMI would whole genome sequence and collect detailed medical data covering 60 major diseases, partnering with life sciences companies to analyze the data for insights. Read more here.
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.
